Covered recipient · General Payments record
MANUEL PEREZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2025
$476.52
- Reported across 18 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.53 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $58.92 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.87 | 2 |
| E.R. Squibb & Sons, L.L.C. | $33.99 | 1 |
| Acerta Pharma LLC | $32.34 | 1 |
| Gilead Sciences, Inc. | $23.54 | 1 |
| EISAI INC. | $20.61 | 1 |
| Incyte Corporation | $17.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $32.34 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206461061 | CMS |
| Daiichi Sankyo Inc. | $29.01 | 09/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197027379 | CMS |
| Daiichi Sankyo Inc. | $29.91 | 09/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197033449 | CMS |
| E.R. Squibb & Sons, L.L.C. | $33.99 | 06/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184406971 | CMS |
| Eisai Inc. | $20.61 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244542889 | CMS |
| Gilead Sciences, Inc. | $23.54 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234489104 | CMS |
| Incyte Corporation | $17.26 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226192269 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.21 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224045996 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.66 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224033342 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.